Indication
Valley Fever
2 clinical trials
2 products
Product
IbrexafungerpClinical trial
Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 (Ibrexafungerp) in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (FURI)Status: Completed, Estimated PCD: 2023-08-17
Clinical trial
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled, Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Single Oral Doses of VT-1598 in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2021-12-27
Product
VT-1598